ScienceDaily (Jan. 4, 2011) — The smoking cessation medications bupropion and varenicline may both be associated with changes in the way the brain reacts to smoking cues, making it easier for patients to resist cravings, according to two reports posted online that will appear in the May print issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
